Your browser doesn't support javascript.
loading
An ACVRL1 gene mutation presenting as vein of Galen malformation at prenatal diagnosis.
De Luca, Caterina; Bevilacqua, Elisa; Badr, Dominique A; Cannie, Mieke M; Sanchez, Teresa C; Segers, Valérie; Keymolen, Kathelijn; Jani, Jacques C.
Afiliação
  • De Luca C; Department of Obstetrics and Gynecology, University Hospital Brugmann, Université Libre de Bruxelles, Brussels, Belgium.
  • Bevilacqua E; Department of Obstetrics and Gynecology, University Hospital Brugmann, Université Libre de Bruxelles, Brussels, Belgium.
  • Badr DA; Department of Obstetrics and Gynecology, University Hospital Brugmann, Université Libre de Bruxelles, Brussels, Belgium.
  • Cannie MM; Department of Radiology, University Hospital Brugmann, Université Libre de Bruxelles, Brussels, Belgium.
  • Sanchez TC; Department of Radiology, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
  • Segers V; Department of Obstetrics and Gynecology, University Hospital Brugmann, Université Libre de Bruxelles, Brussels, Belgium.
  • Keymolen K; Department of Feto-Pathology, University Hospital Brugmann, Université Libre de Bruxelles, Brussels, Belgium.
  • Jani JC; Department of Medical Genetics, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
Am J Med Genet A ; 182(5): 1255-1258, 2020 05.
Article em En | MEDLINE | ID: mdl-32170914
ABSTRACT
Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal dominant disease. The diagnostic criteria of HHT, or Curaçao criteria, include the following recurrent epistaxis or nighttime nose bleeding, mucocutaneous telangiectases, visceral arteriovenous malformation, or an appropriate family history. The diagnosis is classified as definite if three criteria are present, possible if two criteria are present, and unlikely if only one is present. Nowadays, the confirmation of HHT diagnosis is based on molecular genetic studies. It has been showed that only mutations of genes encoding proteins within the transforming growth factor beta signaling pathway were responsible for the manifestation of the disease. The vein of Galen malformation (VOGM) as a presenting sign of HHT is rare. The prenatal diagnosis of HHT is even rarer. Herein, we present a case of prenatally diagnosed case of HHT based on the presence of VOGM in the fetus. To our knowledge, it is the first time that the gene mutation discovered in this case manifested as VOGM in the fetal life.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diagnóstico Pré-Natal / Telangiectasia Hemorrágica Hereditária / Receptores de Activinas Tipo II / Malformações da Veia de Galeno Tipo de estudo: Diagnostic_studies Limite: Adult / Female / Humans / Male / Middle aged / Pregnancy Idioma: En Revista: Am J Med Genet A Assunto da revista: GENETICA MEDICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Bélgica

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diagnóstico Pré-Natal / Telangiectasia Hemorrágica Hereditária / Receptores de Activinas Tipo II / Malformações da Veia de Galeno Tipo de estudo: Diagnostic_studies Limite: Adult / Female / Humans / Male / Middle aged / Pregnancy Idioma: En Revista: Am J Med Genet A Assunto da revista: GENETICA MEDICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Bélgica